<DOC>
	<DOC>NCT00127153</DOC>
	<brief_summary>The purpose of this trial is to evaluate the safety, tolerability, and immunogenicity of an investigational pneumococcal vaccine in healthy adults.</brief_summary>
	<brief_title>A Study of V110 a Pneumococcal Vaccine in Healthy Adults (V110-013)</brief_title>
	<detailed_description />
	<mesh_term>Pneumococcal Infections</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<mesh_term>Heptavalent Pneumococcal Conjugate Vaccine</mesh_term>
	<criteria>Males and females in good health, ages 2040, with no history of pneumococcal vaccination Subjects with a recent febrile illness Known or suspected immune dysfunction, conditions associated with immunosuppression, and receipt of immunosuppressive chemotherapy, including longterm corticosteroid therapy</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>January 2015</verification_date>
</DOC>